Compare INDRAPRASTHA MEDICAL with MEDINOVA DIA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL vs MEDINOVA DIAG. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDRAPRASTHA MEDICAL MEDINOVA DIAG. INDRAPRASTHA MEDICAL/
MEDINOVA DIAG.
 
P/E (TTM) x 17.6 17.6 99.6% View Chart
P/BV x 2.8 - - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 INDRAPRASTHA MEDICAL   MEDINOVA DIAG.
EQUITY SHARE DATA
    INDRAPRASTHA MEDICAL
Mar-20
MEDINOVA DIAG.
Mar-20
INDRAPRASTHA MEDICAL/
MEDINOVA DIAG.
5-Yr Chart
Click to enlarge
High Rs5225 211.7%   
Low Rs2712 237.5%   
Sales per share (Unadj.) Rs90.67.5 1,214.5%  
Earnings per share (Unadj.) Rs4.8-0.2 -2,083.0%  
Cash flow per share (Unadj.) Rs8.40.7 1,153.3%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs29.2-9.2 -317.9%  
Shares outstanding (eoy) m91.679.98 918.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.42.4 18.1%   
Avg P/E ratio x8.4-79.6 -10.5%  
P/CF ratio (eoy) x4.825.0 19.1%  
Price / Book Value ratio x1.4-2.0 -69.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m3,660181 2,019.7%   
No. of employees `000NANA-   
Total wages/salary Rs m2,13919 11,153.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m8,30874 11,155.7%  
Other income Rs m71 928.4%   
Total revenues Rs m8,31575 11,055.1%   
Gross profit Rs m86412 7,229.4%  
Depreciation Rs m33010 3,466.8%   
Interest Rs m596 996.1%   
Profit before tax Rs m482-3 -17,460.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m460 -9,516.7%   
Profit after tax Rs m436-2 -19,133.3%  
Gross profit margin %10.416.0 64.8%  
Effective tax rate %9.517.4 54.5%   
Net profit margin %5.3-3.1 -171.7%  
BALANCE SHEET DATA
Current assets Rs m1,41511 12,791.3%   
Current liabilities Rs m1,39688 1,590.6%   
Net working cap to sales %0.2-103.0 -0.2%  
Current ratio x1.00.1 804.2%  
Inventory Days Days214 15.1%  
Debtors Days Days3517 205.6%  
Net fixed assets Rs m3,07527 11,423.5%   
Share capital Rs m917100 920.7%   
"Free" reserves Rs m1,761-191 -920.7%   
Net worth Rs m2,678-92 -2,919.8%   
Long term debt Rs m040 0.0%   
Total assets Rs m4,49038 11,821.8%  
Interest coverage x9.10.5 1,708.2%   
Debt to equity ratio x0-0.4 0.0%  
Sales to assets ratio x1.92.0 94.4%   
Return on assets %11.09.6 114.5%  
Return on equity %16.32.5 656.2%  
Return on capital %20.2-6.2 -327.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,4080-   
Fx outflow Rs m3440-   
Net fx Rs m1,0640-   
CASH FLOW
From Operations Rs m86512 6,949.4%  
From Investments Rs m-402NA 236,429.4%  
From Financial Activity Rs m-427-11 3,983.6%  
Net Cashflow Rs m352 2,267.1%  

Share Holding

Indian Promoters % 49.4 62.1 79.5%  
Foreign collaborators % 1.6 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 49.0 37.9 129.4%  
Shareholders   59,093 9,582 616.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDRAPRASTHA MEDICAL With:   KAYA  FORTIS HEALTHCARE  CHOKSI LAB.  LOTUS EYE CARE  CHENNAI MEENAKSHI   



Today's Market

Indian Indices End Flat; Nestle, HDFC and ICICI Bank Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

INDRAPRASTHA MEDICAL Announces Quarterly Results (4QFY20); Net Profit Down 9.0% (Quarterly Result Update)

May 26, 2020 | Updated on May 26, 2020

For the quarter ended March 2020, INDRAPRASTHA MEDICAL has posted a net profit of Rs 65 m (down 9.0% YoY). Sales on the other hand came in at Rs 2 bn (up 0.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

INDRAPRASTHA MEDICAL Announces Quarterly Results (2QFY20); Net Profit Up 133.6% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, INDRAPRASTHA MEDICAL has posted a net profit of Rs 179 m (up 133.6% YoY). Sales on the other hand came in at Rs 2 bn (up 8.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

INDRAPRASTHA MEDICAL 2018-19 Annual Report Analysis (Annual Result Update)

Oct 18, 2019 | Updated on Oct 18, 2019

Here's an analysis of the annual report of INDRAPRASTHA MEDICAL for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of INDRAPRASTHA MEDICAL. Also includes updates on the valuation of INDRAPRASTHA MEDICAL.

INDRAPRASTHA MEDICAL Announces Quarterly Results (4QFY20); Net Profit Down 9.0% (Quarterly Result Update)

May 26, 2020 | Updated on May 26, 2020

For the quarter ended March 2020, INDRAPRASTHA MEDICAL has posted a net profit of Rs 65 m (down 9.0% YoY). Sales on the other hand came in at Rs 2 bn (up 0.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

INDRAPRASTHA MEDICAL Announces Quarterly Results (2QFY20); Net Profit Up 133.6% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, INDRAPRASTHA MEDICAL has posted a net profit of Rs 179 m (up 133.6% YoY). Sales on the other hand came in at Rs 2 bn (up 8.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

More Views on News

Most Popular

5 Indian Companies that are Leading the AI Race(Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

5 Specialty Chemical Stocks that Turned Multibaggers in One Year(Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

How to Create a Second Income from Trading(Profit Hunter)

Sep 10, 2021

My trading system that works in all kinds of markets.

A Rare Buying Opportunity in an Exciting Stock(Profit Hunter)

Sep 16, 2021

Whether agriculture sector goes through a structural transformation or not, this agrochemical stock has a good chance of winning.

5 Indian Companies with Over 7% in Dividend Yield(Views On News)

Sep 17, 2021

These stocks will give you better yields than bank deposits.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

INDRAPRASTHA MEDICAL SHARE PRICE


Sep 22, 2021 (Close)

TRACK INDRAPRASTHA MEDICAL

  • Track your investment in INDRAPRASTHA MEDICAL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDRAPRASTHA MEDICAL

INDRAPRASTHA MEDICAL - ASPIRA PATHLAB & DIAGNOSTICS COMPARISON

COMPARE INDRAPRASTHA MEDICAL WITH

MARKET STATS